Pembrolizumab and Induction Chemotherapy in Locally Advanced HNSCC

Clinical trial NCT05272696 · RECRUITING

Trial details

NCT number: NCT05272696
Sponsor: Guangdong Provincial People's Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma

Start date: 2022-03-01
Primary completion: 2026-01-01
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.